Agents to treat Aphthous Stomatitis

Agents to treat aphthous stomatitis represent a functional grouping of topical and systemic therapies rather than a single pharmacologic drug class Their primary therapeutic roles are to alleviate localized pain, suppress T cell–mediated mucosal inflammation, accelerate ulcer re-epithelialization, and decrease the frequency of recurrent outbreaks Clinically, these agents are primarily used to manage idiopathic recurrent aphthous stomatitis (canker sores) as well as aphthous lesions associated wi...

This broad category encompasses mucosal protectants, local anesthetics, topical antiseptics, and anti-inflammatory or immunosuppressive medications—most notably topical corticosteroids and systemic immunomodulators Clinically, these agents are primarily used to manage idiopathic recurrent aphthous stomatitis (canker sores) as well as aphthous lesions associated with systemic conditions, such as Behçet disease and inflammatory bowel disease

Their primary therapeutic roles are to alleviate localized pain, suppress T cell–mediated mucosal inflammation, accelerate ulcer re-epithelialization, and decrease the frequency of recurrent outbreaks